Latest Breaking News On - American institute of ultrasound - Page 6 : vimarsana.com
E-Mail
DALLAS, May 17, 2021 -- Detecting a critical heart defect before birth (congenital heart defects) is less likely when a mother lives in a rural area, lives in a neighborhood with low socioeconomic status or is Hispanic, according to new research published today in the American Heart Association's flagship journal Circulation.
Diagnosing a heart defect before birth reduces infant death rates, increases access to prompt medical treatment, improves neurodevelopmental outcomes and decreases the risk of brain injury for the infant after birth.
"The benefits of prenatal diagnosis for heart defects have been recognized for years, yet prenatal detection occurs in less than 60% of congenital heart disease cases in many U.S. regions," said the study's first author Anita Krishnan, M.D., an associate professor of pediatrics and associate director of echocardiography at Children's National Hospital in Washington, D.C.
MarylandUnited-statesCanadaDallasTexasWashingtonAmericanCanadianMaryt-donofrioWayne-tworetzkyCarol-wittlieb-weberNazia-husainMedical Societies Support Safety and Benefits of Ultrasound Contrast Agents
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adults and children.
All three medical societies issued statements reacting to a recent communication from the Food and Drug Administration “stakeholder engagement staff” citing 13 suspected adverse reactions to polyethylene glycol (PEG), an inactive ingredient in two UCAs, without mentioning that reactions to UCAs are extremely rare and the 13 cases at issue were drawn from historical data representing millions of doses of UCAs administered over more than a decade.
United-statesAmericanStephanie-wilsonLumason-braccoRichard-barrSaint-luke-mid-america-heart-instituteInternational-contrast-ultrasound-societyDrug-administrationAmerican-society-of-echocardiographyAmerican-institute-of-ultrasoundAmerican-instituteAmerican-societyShare:
DETROIT, April 27, 2021 /PRNewswire-PRWeb/ -- Women's Excellence in Obstetrics and Gynecology of southeastern Michigan is excited to announce the expansion of imaging services to a new radiology center in Lake Orion, Michigan. The Women's Radiology Center features advanced ultrasound services, mammography, bone density scans, and body composition analysis.
Dr. Jonathan Zaidan, MD, FACOG, President of Women's Excellence strives to ensure that quality, comprehensive care is accessible and convenient for women. "Our new radiology center allows more women in the community access to high-quality imaging services for preventative and diagnostic care," says Zaidan. "Our team of technicians and radiologists demonstrate excellence in the field of imaging."
United-statesLake-orionMichiganRoyal-oakAmericanJonathan-zaidanAmerican-college-of-radiologyAmerican-institute-of-ultrasoundWomen-radiology-centerRadiology-centerAmerican-instituteAmerican-collegeApr 27, 2021
Clinical guide green lights point-of-care imaging with standard diagnosis in ED, inpatient settings
Clinicians can use add-on point-of-care ultrasonography in patients with unspecified acute dyspnea in the emergency department (ED) or inpatient setting, according to the American College of Physicians (ACP), although the recommendation is based on a low certainty of evidence.
Combining point-of-care ultrasonography (POCUS) with the standard diagnostic pathway increased the proportion of correct diagnoses by 32%, boosted the sensitivity of standard testing without “a substantial tradeoff in specificity,” did not seem to be tied to any serious harms, is not a high-cost test, and did not result in a longer length of stay (LOS) for patients, wrote Amir Qaseem, MD, PhD, MHA, of the ACP in Philadelphia, and co-authors on the college’s clinical guidelines committee.
AustriaItalySaudi-arabiaUnited-statesCanadaPhiladelphiaPennsylvaniaAmericanAmir-qaseemShalmali-palAndrew-rl-medfordGerald-gartlehner